It's not crushing anything since the recent publication of the serious side effects of such drugs.
Now that it's been a couple years since they were "approved", the other shoe is dropping.
this post was submitted on 25 Nov 2024
22 points (92.3% liked)
New York Times gift articles
611 readers
93 users here now
Share your New York Times gift articles links here.
Rules:
- Only post New York Times gift article links.
Info:
- The NYT Open Team. (2021-06-23). “A New Way to Share New York Times Stories”. open.nytimes.com.
- “Gift Articles for New York Times Subscribers”. (n.d.). help.nytimes.com.
Tip:
- Google "unlocked_article_code" and limit search results to the past week.
- Mastodon: Use control-F or ⌘-F to search this page. (ref)
founded 1 year ago
MODERATORS
Being morbidly obese has some serious side effects.
As I understand it, the side effects of ozympic are potentially significant muscle loss, including in the heart.
And muscle that is lost can be regained once you're off of the drugs so for for the most part this seems to be a relatively minor inconvenience, however...
And this is a bit of a doozy...
A decrease in muscle mass will also decrease your BMR. A decrease in your BMR can be permanent or semi-permanent, especially for people who have lost a lot of weight.
This could mean that even if the Ozempic can make you lose a lot of weight it can increase your risk of having a heart attack and also make it so that when you get off of it you might put the weight back on and then some.
But, full results are not in yet, that is just the current concern as I understand it.
I never heard of it until a couple of weeks ago, and now I hear too much. Sounds like serious advertising and marketing dollars are being spent